The question
Human MOTS-c studies do not necessarily involve giving MOTS-c to people. Some measure the peptide already present in the body during exercise. That distinction is central to understanding a prominent 2021 paper that combined human observations with mouse intervention experiments. Original study.
Two experiments inside one research story
Reynolds and colleagues investigated MOTS-c, a mitochondrial-encoded peptide, in relation to exercise and physical function. In mice, administering the peptide improved physical performance under the tested conditions. In the human component, ten young men performed cycling exercise while researchers examined endogenous MOTS-c in muscle and circulation. Those men were not the subjects of the paper's peptide-administration experiments. Nature Communications paper.
Combining these strands can help researchers build a biological hypothesis. For readers, however, combining them into “MOTS-c improves human performance” would erase a crucial experimental boundary. The species and the intervention have to stay attached to each result.
A second exercise study adds nuance
Another 2021 study assigned 30 participants to endurance exercise, resistance exercise or control groups. It reported only a trend toward higher circulating MOTS-c after endurance exercise, while humanin, a different mitochondrial-derived peptide, showed a significant increase. Results for one peptide should not be reassigned to the other. Original exercise study.
This is a good reason to read beyond a broad phrase such as “mitochondrial peptides increased.” Ask which peptide, which sample and which statistical result. Closely related research questions can yield different findings without one sentence capturing them all.
Why a natural response does not prove a treatment
Observing a substance during a physiological process answers a different question from deliberately administering it. A treatment experiment must specify an intervention, an appropriate comparison and outcomes. Even a reproducible association would not independently establish that changing the associated molecule recreates the original process's benefits.
For example, a proposed endurance benefit should be tested with relevant performance measurements in people receiving the actual intervention. A blood concentration after cycling cannot stand in for that comparison. This is an issue of what the experiment measures, not whether the underlying biology is interesting.
Where US safety context fits
FDA reports no identified human exposure data for MOTS-c drug products and flags safety uncertainty, including potential immune reactions. That statement concerns administered products, not whether researchers have measured endogenous MOTS-c. FDA assessment, checked September 24, 2026.
Compounded preparations are not FDA-approved. FDA guidance. Neither the exercise observations nor the mouse experiments should be used as a product approval claim.
The most useful question for a new headline is therefore: were people given the peptide, or was the peptide measured in people? Keep that answer visible while interpreting the result. See what peptides are for terminology and BPC-157 evidence for another example of why study design matters.
Sources & further reading
Research context last reviewed September 24, 2026. Last updated October 6, 2026. Educational reading, not individual medical advice. How this article was prepared.
